Chemical and biological explorations of the family of CC-1065 and the duocarmycin natural products

CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiotics that have been the subject of extensive investigations due to their mode of action and potential in the design of new anticancer therapeutics. The natural products and their analogues exert their...

Full description

Saved in:
Bibliographic Details
Published inCurrent topics in medicinal chemistry Vol. 9; no. 16; p. 1494
Main Authors Ghosh, Nandita, Sheldrake, Helen M, Searcey, Mark, Pors, Klaus
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.11.2009
Subjects
Online AccessGet more information
ISSN1873-4294
DOI10.2174/156802609789909812

Cover

Loading…
Abstract CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiotics that have been the subject of extensive investigations due to their mode of action and potential in the design of new anticancer therapeutics. The natural products and their analogues exert their effects through a sequence selective alkylation of duplex DNA in the minor groove at the N3 of adenine. An understanding of their structure and its effect on biological activity has been derived through chemical synthesis and has also generated new potential lead compounds. These studies form the first section of the review. The desire to progress these compounds to clinic has also led to studies of bioconjugation and prodrug formation and this is discussed in the second section of the review. The combination of synthesis with key biological experiments is a powerful tool to define the requirements for the development of natural products as potential therapeutic agents. The studies described herein form an excellent paradigm for the study and development of other natural products.
AbstractList CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiotics that have been the subject of extensive investigations due to their mode of action and potential in the design of new anticancer therapeutics. The natural products and their analogues exert their effects through a sequence selective alkylation of duplex DNA in the minor groove at the N3 of adenine. An understanding of their structure and its effect on biological activity has been derived through chemical synthesis and has also generated new potential lead compounds. These studies form the first section of the review. The desire to progress these compounds to clinic has also led to studies of bioconjugation and prodrug formation and this is discussed in the second section of the review. The combination of synthesis with key biological experiments is a powerful tool to define the requirements for the development of natural products as potential therapeutic agents. The studies described herein form an excellent paradigm for the study and development of other natural products.
Author Sheldrake, Helen M
Pors, Klaus
Searcey, Mark
Ghosh, Nandita
Author_xml – sequence: 1
  givenname: Nandita
  surname: Ghosh
  fullname: Ghosh, Nandita
  organization: Institute of Cancer Therapeutics, School of Life Sciences, University of Bradford, West Yorkshire BD7 1DP, UK
– sequence: 2
  givenname: Helen M
  surname: Sheldrake
  fullname: Sheldrake, Helen M
– sequence: 3
  givenname: Mark
  surname: Searcey
  fullname: Searcey, Mark
– sequence: 4
  givenname: Klaus
  surname: Pors
  fullname: Pors, Klaus
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19903166$$D View this record in MEDLINE/PubMed
BookMark eNo1j0tLw0AAhBdRtFb_gAfZPxDd9-MoQatQ8NJ72addSHbDJgHz722rnoZvhhmYW3CZSw4APGD0RLBkz5gLhYhAWiqtkVaYXIAVVpI2jGh2DW7w0aZYiBWw7SH0yZkOmuyhTaUrX2cM30NXqplSySMsEU6HAKPpU7ecqG0bjAQ_l06Jn4sztV9cyjCbaa7HhaEWP7tpvANX0XRjuP_TNdi9ve7a92b7ufloX7aNZYJPDRGYOqQEYZ4xFqKMgQjtvENIOk4pMox4TiL2lmKJlNLCIk0FJ9RRb8kaPP7ODrPtg98PNfWmLvv_r-QHtDxS-w
CitedBy_id crossref_primary_10_1021_acs_orglett_6b03209
crossref_primary_10_1016_j_tet_2013_10_012
crossref_primary_10_1016_j_phrs_2024_107341
crossref_primary_10_1124_dmd_122_001011
crossref_primary_10_1016_j_drudis_2020_11_020
crossref_primary_10_1016_j_apsb_2023_06_015
crossref_primary_10_1021_acs_bioconjchem_9b00133
crossref_primary_10_1039_C5NP00091B
crossref_primary_10_1021_acschembio_7b00302
crossref_primary_10_1021_mp500781a
crossref_primary_10_1038_s41467_018_05217_1
crossref_primary_10_1021_acs_molpharmaceut_8b00275
crossref_primary_10_1016_j_drudis_2014_09_009
crossref_primary_10_1158_1535_7163_MCT_12_0405
crossref_primary_10_3762_bjoc_9_107
crossref_primary_10_1021_jo501839x
crossref_primary_10_3390_cancers16193293
crossref_primary_10_1021_ja211098r
crossref_primary_10_1038_s41467_021_27284_7
crossref_primary_10_1021_acschembio_6b00014
crossref_primary_10_1186_1476_4598_12_58
crossref_primary_10_1021_acs_jmedchem_7b00563
crossref_primary_10_1002_ange_201208373
crossref_primary_10_1021_jacsau_2c00448
crossref_primary_10_1021_jacs_9b02453
crossref_primary_10_1021_acs_joc_5b01373
crossref_primary_10_1039_c1cc15638a
crossref_primary_10_1002_cmdc_201402169
crossref_primary_10_1016_j_bmc_2016_04_050
crossref_primary_10_1039_D4CB00203B
crossref_primary_10_1016_j_pharmthera_2017_07_013
crossref_primary_10_1021_acs_orglett_5b00432
crossref_primary_10_1126_science_aar7785
crossref_primary_10_1021_jm4000209
crossref_primary_10_1016_j_bmcl_2018_03_040
crossref_primary_10_52547_ibj_25_3_140
crossref_primary_10_1016_j_bmc_2010_05_078
crossref_primary_10_1016_j_bmcl_2018_03_016
crossref_primary_10_1016_j_tetlet_2018_02_080
crossref_primary_10_1039_D1NP00065A
crossref_primary_10_1021_jm201284m
crossref_primary_10_1002_anie_201208373
crossref_primary_10_1360_TB_2021_1067
crossref_primary_10_1016_j_bmc_2021_116167
crossref_primary_10_3390_biomedicines9030290
crossref_primary_10_1021_acs_orglett_5b02957
crossref_primary_10_1038_nchembio_2448
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2174/156802609789909812
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1873-4294
ExternalDocumentID 19903166
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-b465t-2613c08624d444ef7fe269cdc007c5330a42d52f1db31708896b0936523c3db2
IngestDate Tue Jul 04 17:40:12 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b465t-2613c08624d444ef7fe269cdc007c5330a42d52f1db31708896b0936523c3db2
PMID 19903166
ParticipantIDs pubmed_primary_19903166
PublicationCentury 2000
PublicationDate 2009-11-01
PublicationDateYYYYMMDD 2009-11-01
PublicationDate_xml – month: 11
  year: 2009
  text: 2009-11-01
  day: 01
PublicationDecade 2000
PublicationPlace United Arab Emirates
PublicationPlace_xml – name: United Arab Emirates
PublicationTitle Current topics in medicinal chemistry
PublicationTitleAlternate Curr Top Med Chem
PublicationYear 2009
Score 2.1513023
SecondaryResourceType review_article
Snippet CC-1065, the duocarmycins and yatakemycin are members of a family of ultrapotent antitumour antibiotics that have been the subject of extensive investigations...
SourceID pubmed
SourceType Index Database
StartPage 1494
SubjectTerms Animals
Antibiotics, Antineoplastic - chemistry
Antibiotics, Antineoplastic - pharmacokinetics
Antibiotics, Antineoplastic - therapeutic use
Antineoplastic Agents, Alkylating - chemistry
Antineoplastic Agents, Alkylating - pharmacology
Antineoplastic Agents, Alkylating - therapeutic use
Biological Products - chemistry
Biological Products - pharmacology
Biological Products - therapeutic use
Drug Evaluation, Preclinical
Humans
Indoles - chemistry
Indoles - pharmacology
Indoles - therapeutic use
Pyrrolidinones - chemistry
Pyrrolidinones - pharmacology
Pyrrolidinones - therapeutic use
Title Chemical and biological explorations of the family of CC-1065 and the duocarmycin natural products
URI https://www.ncbi.nlm.nih.gov/pubmed/19903166
Volume 9
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT8IwFG5AX3wxGu-39ME3M2Vbu7FHQzREgyERE97IunaBBBiB8YB_xL_rOe0GFS9RXxbWMlj2fT2X7lwIuVTKCwR3U8cNoshhMo1hScHCiwXY_jAWcg-zkVtPQfOFPXR5t1J5s6KW5rm4Tl6_zCv5D6owBrhiluwfkF3-KAzAZ8AXjoAwHH-F8Ydsf1NOSZ8qHVi3CnJD47LYycDoiwZIxYAvYyflHPTZdLRIBuMrXecTk7NMIdiZbbuWpZzybIKlneHbxYt5LDFS9o1bxvP0s1m_EN9ykC-F_3NfDeU0NiFBWudZHY114uViPYWonZk2bo_DeG2XIirS9bSSMZK1HvoOKD9mi97IZpgtR8FvY18JeHSgcK-BB3UshgYuMGjTqG4isS3EJyMNuQuzvmvauvw8u1Z0u5yqkiq4H9hPtd0yKVd4Bzef_18XnzXXrDko2lDp7JDtwsOgt4Yuu6SixntElFShAAddUYXaVKFZSoEQ1FAFzwqq6ItwxqIKLahCS6rsk879XafRdIr2Go5gAc8d8J39BD1aJhljKg1TWLdRIhMwGxMMOo6ZJ7mXulKAkYnhcIGoRX7APT_xpfAOyMY4G6sjQsGmj3mY1jjuIqpaIlzpg2hXEUh4pkLvmByaJ9KbmBIqvfJZnXw7c0q2Vjw6I5sprFl1DgZgLi40HO9yGFpd
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemical+and+biological+explorations+of+the+family+of+CC-1065+and+the+duocarmycin+natural+products&rft.jtitle=Current+topics+in+medicinal+chemistry&rft.au=Ghosh%2C+Nandita&rft.au=Sheldrake%2C+Helen+M&rft.au=Searcey%2C+Mark&rft.au=Pors%2C+Klaus&rft.date=2009-11-01&rft.eissn=1873-4294&rft.volume=9&rft.issue=16&rft.spage=1494&rft_id=info:doi/10.2174%2F156802609789909812&rft_id=info%3Apmid%2F19903166&rft_id=info%3Apmid%2F19903166&rft.externalDocID=19903166